Lu AA34893
12022A
Phase 2 small_molecule terminated
Quick answer
Lu AA34893 for Depression in Patients With Bipolar Disorder is a Phase 2 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- H. Lundbeck A/S
- Indication
- Depression in Patients With Bipolar Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated